TL;DR
- Lidocaine blocks voltage-gated sodium channels in nerve cell membranes, stopping pain signals before they reach your brain.
- When applied to intact skin at labeled doses, very little lidocaine enters the bloodstream — systemic levels remain far below those needed to affect the heart.
- Heat sources, broken skin, and large application areas all increase the amount of drug absorbed, which is why the label carries specific warnings about each.
What Kind of Drug Is Lidocaine?
Lidocaine is an amide-type local anesthetic. "Amide-type" refers to the chemical structure that puts lidocaine in a distinct class from older anesthetics like benzocaine, which is an ester-type compound. The distinction matters if you ever develop a sensitivity reaction, because allergy to one class does not automatically mean allergy to the other.
The word "local" in local anesthetic means the drug acts at a specific site rather than throughout the whole body. When you apply a lidocaine patch to your knee, the numbing effect is limited to that area of skin and the tissue just beneath it. Your brain does not become sedated, and you do not lose consciousness.
MedlinePlus describes lidocaine as working "by stopping nerves from sending pain signals." That plain-language framing captures the core mechanism well enough for everyday use.
The Nerve Signal Lidocaine Interrupts
To understand what lidocaine does, it helps to know how a pain signal travels.
Your body contains millions of nerve fibers. When tissue is stressed or damaged, nearby nerve endings detect that event and send an electrical impulse — called an action potential — toward your brain. That electrical impulse is powered by sodium ions rushing into the nerve cell through tiny protein gates called voltage-gated sodium channels.
Think of those channels as doors that open and shut very quickly. When enough doors open at once, sodium floods in, the nerve "fires," and the pain signal travels up toward the brain.
Lidocaine closes those doors.
How Lidocaine Reaches the Channels
Here is the sequence of events when you apply a lidocaine patch to your skin.
First, lidocaine molecules in the patch cross the outer layer of skin. The drug molecule exists in two forms at body temperature: an uncharged (neutral) form and a positively charged form. The uncharged form is lipid-soluble — it can pass through the fatty membrane that surrounds nerve cells.
Once inside the nerve cell, the molecule picks up a hydrogen ion from the fluid inside the cell and becomes charged. In that charged form, it binds to the inside face of the sodium channel and holds it closed. Because the channel cannot open, sodium cannot flow in, the nerve cannot fire, and the pain signal stops before it starts. According to StatPearls on NCBI Bookshelf, lidocaine does this by binding reversibly — meaning the effect wears off as the drug is cleared from the site.
The word "reversibly" is important. Lidocaine does not permanently damage nerves at labeled doses. The numbness fades when the drug is removed or absorbed away from the area.
Which Nerve Channels Does It Target?
Lidocaine is not a selective tool. It blocks sodium channels across multiple nerve fiber types, not just the fibers that carry pain signals. Laboratory research has shown that it acts on subtypes including Nav1.7 and Nav1.8, both of which are found in the peripheral nerves involved in pain sensing. However, lidocaine does not preferentially choose pain fibers over other nerve types at the concentrations used in topical products.
In practical terms, this means the patch produces numbness — a reduction in sensation generally — rather than selectively turning off only the pain signal while leaving touch and other sensations fully intact.
At OTC patch doses applied to intact skin, the effect stays largely local. Enough lidocaine does not reach the rest of the body to cause noticeable effects on motor nerves or the cardiovascular system under normal use conditions.
How Much Lidocaine Actually Enters the Bloodstream?
Systemic absorption refers to how much of a drug passes through the skin and into the bloodstream. For topical patches, keeping this number low is a design goal — you want the drug to work at the skin surface, not circulate through your body.
For the prescription 5% Lidoderm patch, mean plasma concentrations measured in clinical studies ranged from approximately 0.1 to 0.2 micrograms per milliliter. According to the Lidoderm FDA prescribing information, that is roughly one-tenth of the concentration associated with the antiarrhythmic (heart-rhythm) effects of systemic lidocaine. In plain terms: the amount that enters the blood is far below the threshold at which the drug starts affecting cardiac function.
Note that those figures come from Lidoderm, the 5% prescription patch. No comparable published pharmacokinetic label data is available for OTC 4% patches, so you should not assume the exact numbers transfer. What does carry over is the general principle: intact skin is a meaningful barrier, and topical application produces far lower blood levels than intravenous or injected lidocaine.
What Changes How Much Is Absorbed?
Three factors can push absorption higher than expected.
Skin condition. The skin's outer layer, the stratum corneum, is the main barrier. If that barrier is broken — by a cut, scrape, rash, sunburn, or skin condition — lidocaine passes through much more readily. MedlinePlus is explicit: the patch should be applied to intact, unbroken skin only.
Application area. A patch covering a large area of skin delivers more drug than the same patch on a small area, simply because more surface is in contact. Using more patches than directed increases total dose delivered.
External heat. Heating pads, electric blankets, saunas, and tanning lamps all dilate blood vessels near the skin and speed up the rate at which lidocaine moves from the patch into the body. The Lidoderm prescribing information warns against using external heat sources while wearing a patch for this reason. This warning applies to prescription patches and is worth treating as a general principle for any lidocaine patch.
Topical vs. Injected: Why the Delivery Method Matters
You may have received an injected lidocaine shot at the dentist or before a minor procedure. That injection delivers a concentrated amount of drug directly to the nerve. The effect is immediate and strong.
A patch works differently. It deposits drug across the skin surface slowly, letting it diffuse down into the tissue. The effect builds gradually. Because absorption through intact skin is limited, the patch cannot match the depth or immediacy of an injection. What it can do is maintain a relatively steady level of drug at the application site over several hours without needles or clinical assistance.
This transdermal delivery route — transdermal meaning across the skin — is why patches are a practical self-care tool for accessible areas of muscle and joint discomfort, while injections remain a clinical-setting procedure for deeper nerve blockade.
When to Talk to a Clinician
The nerve-blocking mechanism of lidocaine is well understood, but that does not mean every pain situation is appropriate for self-treatment with an OTC patch.
If your pain is severe, worsening, or accompanied by symptoms like numbness that travels down a limb, weakness, fever, or loss of bladder or bowel control, stop and consult a clinician rather than reaching for a patch. These symptoms can point to underlying conditions — nerve compression, infection, structural injury — that topical anesthesia will not address and could mask.
If you are pregnant, breastfeeding, or have a history of heart-rhythm problems or liver disease, speak with a clinician or pharmacist before using any lidocaine product. The drug is metabolized primarily by the liver, and conditions that reduce liver function may affect how the drug is cleared, even at low topical doses.
If you are already using another topical anesthetic product anywhere on your body at the same time, the total absorbed amount from all products adds together. Discuss this with a pharmacist before combining topical lidocaine with other numbing products.
Sources
- Lidocaine — StatPearls, NCBI Bookshelf
- MedlinePlus: Lidocaine Transdermal Patch
- Lidoderm 5% FDA Prescribing Information (2015)
- Differential Modulation of Nav1.7 and Nav1.8 by Lidocaine — PMC
- Topical, Local, and Regional Anesthesia — StatPearls/NCBI
Last updated: 2026-05-19
The content on this site is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you are having a medical emergency, call 911 immediately.
